Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunlei Ke

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Pharmaceutical Statistics|October 7, 2022
Treatment effect measures under nonproportional hazardsSteven Snapinn, Qi Jiang, Chunlei Ke
Biometrics|February 19, 2004
Shape-invariant modeling of circadian rhythms with random effects and smoothing spline ANOVA decompositionsYuedong Wang, Chunlei Ke, Morton B Brown
Therapeutic Innovation & Regulatory Science|September 18, 2018
Statistical Considerations on the Evaluation of Imbalances of Adverse Events in Randomized Clinical TrialsHaijun Ma, Chunlei Ke, Qi Jiang, et al.
Journal of Biopharmaceutical Statistics|December 31, 2010
Estimating area under the curve and relative exposure in a pharmacokinetic study with data below quantification limitLiang Fang, Peng Chen, Chunlei Ke, et al.
Clinical Trials (London, England)|August 11, 2012
The issue of multiplicity in noninferiority studiesChunlei Ke, Beiying Ding, Qi Jiang, et al.
Pharmaceutical Statistics|December 23, 2015
Predicting analysis time in events-driven clinical trials using accumulating time-to-event surrogate informationJianming Wang, Chunlei Ke, Zhinuan Yu, et al.
Statistics in Medicine|February 21, 2012
Predicting analysis time in event-driven clinical trials with event-reporting lagJianming Wang, Chunlei Ke, Qi Jiang, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Choosing Appropriate Metrics to Evaluate Adverse Events in Safety EvaluationYing Zhou, Chunlei Ke, Qi Jiang, et al.
Statistics in Medicine|August 25, 2022
Synthesizing studies for comparing different treatment sequences in clinical trialsGuoqing Diao, Haijun Ma, Donglin Zeng, et al.
Journal of Biopharmaceutical Statistics|February 14, 2018
Biomarker threshold adaptive designs for survival endpointsGuoqing Diao, Jun Dong, Donglin Zeng, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Pharmaceutical Statistics|October 7, 2022
Treatment effect measures under nonproportional hazardsSteven Snapinn, Qi Jiang, Chunlei Ke
Biometrics|February 19, 2004
Shape-invariant modeling of circadian rhythms with random effects and smoothing spline ANOVA decompositionsYuedong Wang, Chunlei Ke, Morton B Brown
Therapeutic Innovation & Regulatory Science|September 18, 2018
Statistical Considerations on the Evaluation of Imbalances of Adverse Events in Randomized Clinical TrialsHaijun Ma, Chunlei Ke, Qi Jiang, et al.
Journal of Biopharmaceutical Statistics|December 31, 2010
Estimating area under the curve and relative exposure in a pharmacokinetic study with data below quantification limitLiang Fang, Peng Chen, Chunlei Ke, et al.
Clinical Trials (London, England)|August 11, 2012
The issue of multiplicity in noninferiority studiesChunlei Ke, Beiying Ding, Qi Jiang, et al.
Pharmaceutical Statistics|December 23, 2015
Predicting analysis time in events-driven clinical trials using accumulating time-to-event surrogate informationJianming Wang, Chunlei Ke, Zhinuan Yu, et al.
Statistics in Medicine|February 21, 2012
Predicting analysis time in event-driven clinical trials with event-reporting lagJianming Wang, Chunlei Ke, Qi Jiang, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Choosing Appropriate Metrics to Evaluate Adverse Events in Safety EvaluationYing Zhou, Chunlei Ke, Qi Jiang, et al.
Statistics in Medicine|August 25, 2022
Synthesizing studies for comparing different treatment sequences in clinical trialsGuoqing Diao, Haijun Ma, Donglin Zeng, et al.
Journal of Biopharmaceutical Statistics|February 14, 2018
Biomarker threshold adaptive designs for survival endpointsGuoqing Diao, Jun Dong, Donglin Zeng, et al.
Pageof 2